SGK1 and breast cancer: The study led to an intricate convergence model indicating a dual-phase regulation downstream to progesterone to regulate the expression of its direct transcriptional target serum- and glucocorticoid-regulated kinase 1, SGK1, and downregulation of miR-29a and miR-101-1 targeting SGK1 in breast cancer cells.